259 related articles for article (PubMed ID: 31032735)
21. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.
Barrio-Real L; Benedetti LG; Engel N; Tu Y; Cho S; Sukumar S; Kazanietz MG
Breast Cancer Res; 2014 Sep; 16(5):441. PubMed ID: 25248717
[TBL] [Abstract][Full Text] [Related]
22. Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX.
Filipenko NR; Attwell S; Roskelley C; Dedhar S
Oncogene; 2005 Sep; 24(38):5837-49. PubMed ID: 15897874
[TBL] [Abstract][Full Text] [Related]
23. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase.
Montalvo-Ortiz BL; Castillo-Pichardo L; Hernández E; Humphries-Bickley T; De la Mota-Peynado A; Cubano LA; Vlaar CP; Dharmawardhane S
J Biol Chem; 2012 Apr; 287(16):13228-38. PubMed ID: 22383527
[TBL] [Abstract][Full Text] [Related]
24. Feedback regulation between phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 and transforming growth factor β1 and prognostic value in gastric cancer.
Shao Q; Chen ZM
World J Gastroenterol; 2020 Jan; 26(1):21-34. PubMed ID: 31933512
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.
Okamoto H; Takuwa N; Yokomizo T; Sugimoto N; Sakurada S; Shigematsu H; Takuwa Y
Mol Cell Biol; 2000 Dec; 20(24):9247-61. PubMed ID: 11094076
[TBL] [Abstract][Full Text] [Related]
26. Activation of the mevalonate pathway in response to anti-cancer treatments drives glioblastoma recurrences through activation of Rac-1.
He L; Ioannidis A; Arambula E; Hoffman CJ; Joshi P; Kathiravan A; Whitelegge J; Liau LM; Kornblum HI; Pajonk F
bioRxiv; 2023 Jul; ():. PubMed ID: 37546917
[TBL] [Abstract][Full Text] [Related]
27. Regulation of p70 S6 kinase by complex formation between the Rac guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin.
Buchsbaum RJ; Connolly BA; Feig LA
J Biol Chem; 2003 May; 278(21):18833-41. PubMed ID: 12531897
[TBL] [Abstract][Full Text] [Related]
28. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.
Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA
Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540
[TBL] [Abstract][Full Text] [Related]
29. ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma.
Ryan MB; Finn AJ; Pedone KH; Thomas NE; Der CJ; Cox AD
Mol Cancer Res; 2016 Oct; 14(10):1009-1018. PubMed ID: 27418645
[TBL] [Abstract][Full Text] [Related]
30. P-Rex1 directly activates RhoG to regulate GPCR-driven Rac signalling and actin polarity in neutrophils.
Damoulakis G; Gambardella L; Rossman KL; Lawson CD; Anderson KE; Fukui Y; Welch HC; Der CJ; Stephens LR; Hawkins PT
J Cell Sci; 2014 Jun; 127(Pt 11):2589-600. PubMed ID: 24659802
[TBL] [Abstract][Full Text] [Related]
31. p21-activated Kinases (PAKs) Mediate the Phosphorylation of PREX2 Protein to Initiate Feedback Inhibition of Rac1 GTPase.
Barrows D; Schoenfeld SM; Hodakoski C; Silkov A; Honig B; Couvillon A; Shymanets A; Nürnberg B; Asara JM; Parsons R
J Biol Chem; 2015 Nov; 290(48):28915-31. PubMed ID: 26438819
[TBL] [Abstract][Full Text] [Related]
32. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway.
Arai A; Kanda E; Miura O
Oncogene; 2002 Apr; 21(17):2641-51. PubMed ID: 11965537
[TBL] [Abstract][Full Text] [Related]
33. The GTP-binding protein Rac does not couple PI 3-kinase to insulin-stimulated glucose transport in adipocytes.
Marcusohn J; Isakoff SJ; Rose E; Symons M; Skolnik EY
Curr Biol; 1995 Nov; 5(11):1296-302. PubMed ID: 8574587
[TBL] [Abstract][Full Text] [Related]
34. The small GTPase RhoG mediates glioblastoma cell invasion.
Kwiatkowska A; Didier S; Fortin S; Chuang Y; White T; Berens ME; Rushing E; Eschbacher J; Tran NL; Chan A; Symons M
Mol Cancer; 2012 Sep; 11():65. PubMed ID: 22966858
[TBL] [Abstract][Full Text] [Related]
35. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways.
Reif K; Nobes CD; Thomas G; Hall A; Cantrell DA
Curr Biol; 1996 Nov; 6(11):1445-55. PubMed ID: 8939609
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway.
Chikano Y; Domoto T; Furuta T; Sabit H; Kitano-Tamura A; Pyko IV; Takino T; Sai Y; Hayashi Y; Sato H; Miyamoto K; Nakada M; Minamoto T
Mol Cancer Ther; 2015 Feb; 14(2):564-74. PubMed ID: 25504636
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement.
Higginbotham K; Tian Y; Gawlak G; Moldobaeva N; Shah A; Birukova AA
Cell Signal; 2014 Nov; 26(11):2306-16. PubMed ID: 25101856
[TBL] [Abstract][Full Text] [Related]
38. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
[TBL] [Abstract][Full Text] [Related]
39. Development of EHop-016: a small molecule inhibitor of Rac.
Dharmawardhane S; Hernandez E; Vlaar C
Enzymes; 2013; 33 Pt A(Pt A):117-46. PubMed ID: 25033803
[TBL] [Abstract][Full Text] [Related]
40. Activation of Rac1 by Src-dependent phosphorylation of Dock180(Y1811) mediates PDGFRα-stimulated glioma tumorigenesis in mice and humans.
Feng H; Hu B; Liu KW; Li Y; Lu X; Cheng T; Yiin JJ; Lu S; Keezer S; Fenton T; Furnari FB; Hamilton RL; Vuori K; Sarkaria JN; Nagane M; Nishikawa R; Cavenee WK; Cheng SY
J Clin Invest; 2011 Dec; 121(12):4670-84. PubMed ID: 22080864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
